Showing results (221-230 of 270) with videos related to
Sort By:
Pageof 27
Journal of Crohn'S & Colitis|July 24, 2021
The Reliability and Accuracy of Endoscopic Items and Scores Used in the Assessment of the Ileoanal Pouch and CuffZaid S Ardalan, Danny Con, Sujievvan Chandran, et al.Gastroenterology|November 6, 2017
Fructan, Rather Than Gluten, Induces Symptoms in Patients With Self-Reported Non-Celiac Gluten SensitivityGry I Skodje, Vikas K Sarna, Ingunn H Minelle, et al.Trials|July 28, 2021
Microbial Interventions to Control and Reduce Blood Pressure in Australia (MICRoBIA): rationale and design of a double-blinded randomised cross-over placebo controlled trialDakota Rhys-Jones, Rachel E Climie, Paul A Gill, et al.Alimentary Pharmacology & Therapeutics|January 10, 2025
Blood Group B May Reduce Risk of Rebleeding in Patients With Upper Gastrointestinal Haemorrhage due to Peptic Ulcer DiseaseSarah Taylor, Lynna Chen, Krishneel Dutt, et al.Gut|February 26, 2013
Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II studySimon P L Travis, Silvio Danese, Limas Kupcinskas, et al.Inflammatory Bowel Diseases|July 9, 2018
Continuous Clinical Response Is Associated With a Change of Disease Course in Patients With Moderate to Severe Ulcerative Colitis Treated With GolimumabWalter Reinisch, Jean-Frederic Colombel, Peter R Gibson, et al.Journal of Crohn'S & Colitis|July 24, 2021
Accuracy of Gastrointestinal Ultrasound and Calprotectin in the Assessment of Inflammation and its Location in Patients with an Ileoanal PouchZaid S Ardalan, Antony B Friedman, Danny Con, et al.Alimentary Pharmacology & Therapeutics|December 15, 2021
Ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in uteroEmma Flanagan, Ralley Prentice, Emily K Wright, et al.Alimentary Pharmacology & Therapeutics|May 4, 2025
Clinical Trial: Effect of a 28-Day Low FODMAP Diet on Gastrointestinal Symptoms Associated With Endometriosis (EndoFOD)-A Randomised, Controlled Crossover Feeding StudyJane E Varney, Daniel So, Peter R Gibson, et al.Journal of Crohn'S & Colitis|June 20, 2018
Long-Term Benefit of Golimumab for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the PURSUIT-Maintenance ExtensionWalter Reinisch, Peter R Gibson, William J Sandborn, et al.Pageof 27